ESRX - Express Scripts Holding Company
| Previous Close | 96.15 |
| Open | 95.62 |
| Bid | 95.00 x 900 |
| Ask | 95.30 x 800 |
| Day's Range | 94.94 - 96.96 |
| 52 Week Range | 58.23 - 97.22 |
| Volume | 1,902,679 |
| Avg. Volume | 4,302,076 |
| Market Cap | 53.57B |
| Beta (3Y Monthly) | 1.19 |
| PE Ratio (TTM) | 11.61 |
| EPS (TTM) | 8.21 |
| Earnings Date | Oct 31, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | 2003-11-12 |
| 1y Target Est | 89.58 |
- Investor's Business Daily•21 hours ago
IBD Stock Of The Day Cigna Nears Buy Point After Fighting Off Merger Doubts
Stock of The Day: Cigna battled doubters for months over its $67 billion Express Scripts takeover. Now, as the deal is almost done, Cigna stock is near a buy point.
Markit•2 days agoSee what the IHS Markit Score report has to say about Express Scripts Holding Co.
Express Scripts Holding Co NASDAQ/NGS:ESRX
- Reuters•3 days ago
Exclusive: Express Scripts covers Amgen, Lilly migraine drugs, excludes Teva
Express Scripts Holding Co, one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers. The decision represents a setback for Israel-based Teva , which is in the midst of a corporate restructuring and had hoped to capture a sizable share of the multibillion-dollar migraine market. Express Scripts is also taking steps to limit use of the Amgen and Lilly migraine drugs to patients it says are most likely to benefit from them.
Reuters•3 days agoExpress Scripts covers Amgen, Lilly migraine drugs, excludes Teva
Express Scripts Holding Co, one of the largest U.S. prescription benefits managers, will cover new migraine drugs from Eli Lilly and Amgen Inc, but exclude a rival medication from Teva Pharmaceutical Industries Ltd after price negotiations with all three manufacturers. The decision represents a setback for Israel-based Teva , which is in the midst of a corporate restructuring and had hoped to capture a sizable share of the multibillion-dollar migraine market. Express Scripts is also taking steps to limit use of the Amgen and Lilly migraine drugs to patients it says are most likely to benefit from them.
- PR Newswire•3 days ago
Express Scripts Offers New Value-Based Program for Migraine
Industry first SafeGuardRx Migraine Care Value Program Brings Affordability to Migraine Prevention and Treatment for Patients and Payers ST. LOUIS , Oct. 17, 2018 /PRNewswire/ -- Migraine headaches are ...
- PR Newswire•4 days ago
Express Scripts Holding Company Announces Third Quarter 2018 Earnings Release Details
ST. LOUIS , Oct. 16, 2018 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) (" Express Scripts ") announced today its intention to release its 2018 third quarter financial results ...
- Zacks•5 days ago
What's in Store for Express Scripts' (ESRX) Q3 Earnings?
Express Scripts (ESRX) likely to see soft PBM revenues in the third quarter of 2018; guidance strong.
- Zacks•10 days ago
Express Scripts Introduces Medicare PDP Offerings for 2019
Express Scripts' (ESRX) Medicare PDP to initiate coverage from Jan 1, 2019. The plan includes Walmart along with CVS Pharmacy and the Kroger Family of Pharmacies.
- TheStreet.com•10 days ago
Express Scripts' Stock Has a Prescription for Further Gains
Prices are above the rising 50-day moving average line and the bullish 200-day moving average line. Successful tests of the 200-day line can be seen in April, May and the beginning of August. The daily On-Balance-Volume (OBV) line shows a positive bias with a new rise from early August.
- CNBC•11 days ago
Cramer's lightning round: Buy Express Scripts on its upcoming merger
Jim Cramer opines on callers' favorite stocks at lightning speed, including a health-care play being absorbed by Cigna.
- PR Newswire•11 days ago
Express Scripts Readies Emergency Support for Impacted Members in Advance of Hurricane Michael
ST. LOUIS, Oct. 9, 2018 /PRNewswire/ -- In advance of the expected landfall later this week of Hurricane Michael, Express Scripts reminds patients to include their prescription medications in their emergency plans by printing their medication history, securing vital prescription drugs, and ensuring adequate medication supplies. In accordance with State of Emergency declarations in Georgia, Express Scripts (ESRX) has implemented emergency procedures for its members in these areas, including Medicare, Medicaid and TRICARE® beneficiaries, and patients who fill medications via the company's Accredo specialty pharmacy. Members in an affected area can obtain an early refill to ensure they have enough medication on hand prior to the storm, or to replace any medication that is lost or damaged as a result of the storm.
- PR Newswire•11 days ago
Express Scripts Readies Emergency Support for Impacted Members in Advance of Hurricane Michael
ST. LOUIS, Oct. 9, 2018 /PRNewswire/ -- In advance of the expected landfall later this week of Hurricane Michael, Express Scripts reminds patients to include their prescription medications in their emergency plans by printing their medication history, securing vital prescription drugs, and ensuring adequate medication supplies. In accordance with State of Emergency declarations in Alabama and Florida, Express Scripts (ESRX) has implemented emergency procedures for its members in these areas, including Medicare, Medicaid and TRICARE® beneficiaries, and patients who fill medications via the company's Accredo specialty pharmacy. Members in an affected area can obtain an early refill to ensure they have enough medication on hand prior to the storm, or to replace any medication that is lost or damaged as a result of the storm.
- PR Newswire•11 days ago
Express Scripts Introduces Medicare Part D Plan Offerings for 2019
ST. LOUIS, Oct. 9, 2018 /PRNewswire/ -- Express Scripts (ESRX) today introduced its Express Scripts Medicare® Prescription Drug Plan (PDP) offerings for 2019, offering seniors three high-value options for coverage and savings. The company's popular, low-premium Saver plan, which made its debut in 2018, will continue to provide affordable access to more than 2,800 commonly used medications while offering an expanded preferred pharmacy network that will now include Walmart in addition to CVS Pharmacy® and the Kroger Family of Pharmacies.
- Zacks•12 days ago
Express Scripts' Accredo & Akcea Tie Up to Distribute TEGSEDI
Express Scripts (ESRX) likely to gain market traction through distribution of TEGSEDI.
- Investor's Business Daily•12 days ago
IBD Stock Of The Day Forms New Buy Point After 32% Run
IBD Stock Of The Day: Centene has a new buy point after rallying from an April breakout. Managed care stocks have been winners in 2018, and are holding up well now.
- InvestorPlace•12 days ago
10 Stocks to Buy As They Soar Higher in Q4 and Beyond
All these stocks share a “Buy” consensus from the Street and compelling upside potential to match. This is a core Permian Basin large cap with a strong track record of execution. Given this, the Williams Capital analyst reaffirms his buy rating with a $189 price target (19% upside potential).
Markit•12 days agoSee what the IHS Markit Score report has to say about Express Scripts Holding Co.
Express Scripts Holding Co NASDAQ/NGS:ESRX
- GlobeNewswire•15 days ago
Akcea Announces Its Access and Distribution Strategy for TEGSEDI™ (inotersen)
Akcea Therapeutics, Inc. (AKCA), an affiliate of Ionis Pharmaceuticals, Inc.(IONS), announced today that they are working together with Accredo® specialty pharmacy, a subsidiary of Express Scripts (ESRX), to distribute TEGSEDI™ (inotersen) subcutaneous injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis in adults. Approved by the U.S. Food and Drug Administration (FDA) today, TEGSEDI is the first and only subcutaneous RNA-targeting therapeutic offering patients an effective treatment for the polyneuropathy of hATTR amyloidosis.
- PR Newswire•17 days ago
Express Scripts Flattens the Trajectory of the Diabetes Epidemic with SafeGuardRx Diabetes Care Value® Program
- In its first year, the Express Scripts Diabetes Care Value program delivered nearly $43 million savings for plans; reduced heart attack risk in 15 percent of patients ST. LOUIS , Oct. 3, 2018 /PRNewswire/ ...
- Zacks•18 days ago
Cigna Gets Merger Nod, Forms Management for Unified Entity
Cigna (CI) forms management as it prepares for new merged entity.
- CNBC•18 days ago
Hedge funds in the business of breaking up deals see big payoff, study finds
So-called activist arbitrageurs create an extra, risk-adjusted, 5.7 percent bounce in the shares of acquirers, researchers at Columbia University and the University of Florida say.
GuruFocus.com•19 days ago6 Predictable Stocks With Wide Margins of Safety
According to the GuruFocus All-in-One Screener , the following stocks have high business predictability ratings and a wide margin of safety. Warning! GuruFocus has detected 4 Warning Signs with CAI. The company has a three-star business predictability rating and, according to the discounted cash flow calculator, has a 53% margin of safety at $22.87 per share.
- PR Newswire•19 days ago
Inside Rx Announces Access to Fertility Services for Uninsured Americans with Freedom FP Fertility Pharmacy
FRANKLIN LAKES, N.J., Oct. 1, 2018 /PRNewswire/ -- Inside Rx, LLC, a partially owned subsidiary of Express Scripts (ESRX) that provides discounted medications for uninsured and underinsured Americans, today announced it is collaborating with Freedom FP Fertility Pharmacy to promote more affordable access to fertility treatments and specialized care. Freedom FP Fertility Pharmacy can help connect eligible patients who are uninsured or who have exhausted their plan's fertility coverage with discounts and financial support for fertility therapy, while fertility pharmacists help patients through the complex treatment process, administration of therapy and other unique care needs.
- Zacks•22 days ago
Aetna a Step Closer to CVS Merger, Sells Medicare Business
Aetna (AET) gets a step closer to its merger with CVS Health by selling its Medicare business to WellCare Health.
